CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX)

Q: What does CUSIP 23284F105 represent in this 13F holders report?

CUSIP 23284F105 is the security identifier for CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q2 2018?

139 institutional investors reported CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 23284F105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 217,291,620
Total 13F shares: 32,308,752
Share change: +3,107,822
Total reported value: $738,633,935
Put/Call ratio: 9.6%
Price per share: $22.86
Number of holders: 139
Value change: +$66,042,910
Number of buys: 85
Number of sells: 62

Quarterly Holders Quick Answers

What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 23284F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	2.7%	5,791,673	$164,774,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	2,872,432	$81,721,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	1.2%	2,510,305	$71,418,000	—	31 Mar 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1%	2,208,812	$62,841,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.67%	1,463,883	$41,648,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.53%	1,152,958	$32,805,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.44%	961,200	$27,346,000	—	31 Mar 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.35%	753,322	$21,432,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.27%	594,788	$16,922,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.22%	474,498	$13,499,000	—	31 Mar 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.22%	472,949	$13,455,000	—	31 Mar 2018	13F
FIL Ltd	13F	Company	0.2%	429,925	$12,231,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.19%	419,352	$11,930,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.19%	418,892	$11,917,000	—	31 Mar 2018	13F
Man Group plc	13F	Company	0.19%	407,483	$11,593,000	—	31 Mar 2018	13F
Redmile Group, LLC	13F	Company	0.15%	334,680	$9,522,000	—	31 Mar 2018	13F
FRANKLIN RESOURCES INC	13F	Company	0.15%	333,500	$9,488,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	330,274	$9,395,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.15%	323,015	$9,190,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.13%	290,700	$8,270,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.12%	265,045	$7,541,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.1%	209,801	$5,969,000	—	31 Mar 2018	13F
Casdin Capital, LLC	13F	Company	0.1%	207,500	$5,903,000	—	31 Mar 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.09%	205,060	$5,834,000	—	31 Mar 2018	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.09%	201,876	$5,743,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	201,061	$5,720,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	199,664	$5,680,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	198,366	$5,644,000	—	31 Mar 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.09%	191,201	$5,439,000	—	31 Mar 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	188,800	$5,371,000	—	31 Mar 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.08%	180,000	$5,121,000	—	31 Mar 2018	13F
Granahan Investment Management, LLC	13F	Company	0.07%	162,592	$4,626,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.07%	159,014	$4,524,000	—	31 Mar 2018	13F
PointState Capital LP	13F	Company	0.07%	154,000	$4,381,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.07%	143,823	$4,092,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.06%	135,492	$3,854,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.06%	134,407	$3,824,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.06%	125,932	$3,583,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	124,030	$3,529,000	—	31 Mar 2018	13F
Congress Park Capital LLC	13F	Company	0.05%	107,725	$3,065,000	—	31 Mar 2018	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.05%	104,706	$2,979,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	83,984	$2,387,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	77,515	$2,205,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	77,298	$2,199,000	—	31 Mar 2018	13F
Vident Investment Advisory, LLC	13F	Company	0.04%	79,143	$2,174,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	74,270	$2,113,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	73,289	$2,086,000	—	31 Mar 2018	13F
AMP Capital Investors Ltd	13F	Company	0.03%	66,621	$1,871,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.03%	65,000	$1,849,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	59,601	$1,695,000	—	31 Mar 2018	13F

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) as of Q2 2018

As of 30 Jun 2018, CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) was held by 139 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,308,752 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Aquilo Capital Management, LLC, and FIL Ltd. This page lists 139 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

136

Q2 2018 holders

139

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.